Source: FinanzNachrichten

BioNxt: BioNxt Solutions Inc.: BioNxt Solutions Prepares for Human Bioequivalence Study For MS

VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delive...

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Hugh Rogers's photo - CEO of BioNxt

CEO

Hugh Rogers

CEO Approval Rating

90/100

Read more